Patent details

EP2371396 Title: Truncated fragments of alpha synuclein in lewy body disease

Basic Information

Publication number:
EP2371396
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP111555272
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Truncated fragments of alpha synuclein in lewy body disease
French Title of Invention:
Fragments tronqués d'alpha-synucléine dans une maladie à corps de Lewy
German Title of Invention:
Verkürzte Alpha-Synuklein-Fragmente in der Lewy-Körper-Krankheit
SPC Number:

Dates

Filing date:
19/10/2005
Grant date:
15/01/2014
EP Publication Date:
15/01/2014
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/10/2011
EP B1 Publication Date:
15/01/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/10/2014
Expiration date:
19/10/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/10/2005
 
 

Name:
Elan Pharmaceuticals LLC
Address:
300 Technology Square, Third Floor, Cambridge, MA, United States (US)

Inventor

1

Name:
Goldstein Jason
Address:
United States (US)

2

Name:
Chilcote Tamie J.
Address:
United States (US)

3

Name:
Anderson John P.
Address:
United States (US)

4

Name:
Walker Donald
Address:
United States (US)

Priority

1

Priority Number:
969335
Priority Date:
19/10/2004
Priority Country:
United States (US)

2

Priority Number:
194115
Priority Date:
29/07/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 49/00;
Filing date Document type Number of pages